Caldwell Sutter Capital’s Zimmer Biomet ZBH Stock Holding History

Caldwell Sutter Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55K	Hold	18	–	–	﹤0.01%	826
2026 Q1	$1.63K	Hold	18	–	–	﹤0.01%	773
2025 Q4	$1.62K	Hold	18	–	–	﹤0.01%	770
2025 Q3	$1.77K	Hold	18	–	–	﹤0.01%	751
2025 Q2	$1.64K	Hold	18	–	–	﹤0.01%	735
2025 Q1	$2.04K	Hold	18	–	–	﹤0.01%	731
2024 Q4	$1.9K	Hold	18	–	–	﹤0.01%	752
2024 Q3	$1.94K	Hold	18	–	–	﹤0.01%	761
2024 Q2	$1.95K	Hold	18	–	–	﹤0.01%	759
2024 Q1	$2.38K	Hold	18	–	–	﹤0.01%	739
2023 Q4	$2.19K	Hold	18	–	–	﹤0.01%	748
2023 Q3	$2.02K	Hold	18	–	–	﹤0.01%	735
2023 Q2	$2.62K	Buy	+18	New	+$2.45K	﹤0.01%	700

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Caldwell Sutter Capital's ZBH Position: Q2 2026 in Review

Caldwell Sutter Capital held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 18 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #826.

Caldwell Sutter Capital first reported a position in ZBH in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.62K in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Caldwell Sutter Capital held 18 shares of Zimmer Biomet worth $1.55K as of Q2 2026.
Caldwell Sutter Capital left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #826 holding.
Caldwell Sutter Capital first reported a position in Zimmer Biomet in Q2 2023 and has held it in 13 quarters since.
Caldwell Sutter Capital's Zimmer Biomet position peaked at $2.62K in Q2 2023.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.